- This event has passed.
Genomic Medicine 2017 Benelux
November 14, 2017 - November 16, 2017
Genomic Medicine 2017 BeneluxWorkshop: 14 November / Conference: 15 - 16 November
Genomic Medicine 2017 Benelux, was the second annual genomics event – following on from NGS 2016 Benleux – that took place in Brussels and was held between 14th & 16th November 2017 at the Musée de la Médecine (Museum of Medicine), Campus Erasme, Brussels.
The conference took place on 15th & 16th November and was a partnership between Biotexcel, Université Libre de Bruxelles (ULB) & the University Hospital Erasme, BRIGHTcore & the Centre for Medical Genetics VUB- UZ Brussel – and the scientific committee was made up of staff from all these organizations.
In conjunction with the conference there was a one day Workshop on 14th November that provided Next Generation Sequencing Data Analysis training to those working in the wetlab who want to be able to analyse the data and understand the data analysis workflows.
The conference looked at the latest developments in the use of Genomics tools & technologies focusing on Next Generation Sequencing (NGS) to understand human disease. Aside from the routine NGS applications such as Exome, Genome and Transcriptome sequencing the audience got a chance to hear about evolving tools and applications. We took a look at interesting case studies, applications with limiting sample input, linkage between the microbiome and human disease, cancer genomics new data analysis and storage solutions and many other topics.
NETWORKING: in addition to the excellent science, Genomic Medicine 2017 Benelux allowed delegates to interact with each other during networking events. These networking opportunities included:
- Introductory networking session on Day 1
- Panel debate
- Networking dinner on the evening of 15th Nov.
Who attended the event:
- NGS users, researchers and students
- NHS & Private Labs, Biotech Companies, CRO’s, Service Providers
…and others interested in the latest developments of:
- Next Generation Sequencing
- Computational Biology
- Data Analysis
- Data interpretation
- DNA Sequencing
- Infectious and Inherited Diseases
- NGS Data Storage
- Molecular and Cell Biology
- Molecular Diagnostics
|09.00 – 10.30:||Registration, Coffee & Networking|
|10.30 – 11.00:||Ed Quazi – Networking and Collaborations Workshop|
|SESSION CHAIR: Dr Jana Jeschke|
|11.00 – 11.30:||Prof Marc Abramowicz, Medical Genetics, Hospital Erasme – ULB
Assessing evidence for Genomic Medicine
|11.30 – 12.00:||Prof Wim Vranken, Vrije Universiteit Brussel
MutaFrame: A software framework for identifying molecular causes of human diseases
|12.00 – 12.30:||TECHNOLOGY PRESENTATION by Dr Björn Textor, New England Biolabs (NEB)
Novel sample preparation approaches for translational genomics
|12.30 – 13.30:||Lunch, Exhibition, Networking|
|SESSION CHAIR: Dr Björn Fischer-Zirnsak
|13.30 – 14.00:||Prof Aarno Palotie, FIMM, University of Helsinki, Finland
Using Nordic Health Register data and a population isolate in disease genetics
|14.00 – 14.30:||Prof Nisha Limaye, Institut de Duve
Venous Malformation: From gene discovery to targeted therapy, powered by NGS
|14.30 – 15.00:||TECHNOLOGY PRESENTATION by Dr Pierre Bourbon, Bluebee
Improving healthcare by deploying simplified, compliant, affordable and harmonized NGS Analytics
|15.00 – 15.30:||Coffee, Exhibition & Networking|
|15.30 – 16.00:||Prof Edwin Cuppen, Hartwig Medical Foundation, The Netherlands
National scale tumor whole genome sequencing for personalized cancer treatment in the Netherlands
|16.00 – 16.30:||Prof Jean-Louis Mandel, University of Strasbourg
GenIDA project: a family-oriented international online clinical database for genetic forms of intellectual disability
|16.30 – 17.00:||Prof Gert Matthijs, KU Leuven
Genomic Medicine: How should the National Health System deal with it?
|17.00 – 18.00:||PANEL DEBATE: Topical issues and Bottlenecks
Would you sequence your genome and publish the data? And other topical Issues from the morning workshop.
Host: Ed Quazi
Panellists: Nisha Limaye, Yahya Anvar, Edwin Cuppen, Jana Jeschke, Gert Matthijs
|19.30:||NETWORKING DINNER (booking required)|
|SESSION CHAIR: Prof Nisha Limaye|
|09.00 – 09.30:||Dr Claude Houdayer, Institut Curie – Oncogenetics, Paris
Panel testing in hereditary cancer
|09.30 – 10.00:||Dr Björn Fischer-Zirnsak, Charité, Berlin
Segmental progeroid disorders: NGS approaches and functional studies
|10.00 – 10.30:||TECHNOLOGY PRESENTATION by Dr Fabio Maretto, PerkinElmer
Extraction to analysis, PerkinElmer’s solutions to accelerate your NGS workflow
|10.30 – 11.00:||Coffee, Exhibition & Networking|
|11.00 – 11.30:||Dr Yahya Anvar, Leiden University Medical Center
Personalized therapeutics: from genome to functional divergence
|11.30 – 12.00:||Prof Tom Lenaerts, ULB & VUB
Towards the automatic identification of digenic diseases; from data to the first predictors
|12.00 – 12.30:||TECHNOLOGY PRESENTATION by Dr Winfried van Eyndhoven, Agilent
New developments towards ultra-low variant detection and gene expression profiling in clinical cancer diagnostics
|12.30 – 13.30:||Lunch, Exhibition & Networking|
|SESSION CHAIR: Prof Wim Vranken|
|13.30 – 14.00:||Prof Rejko Krüger, Luxembourg Centre for Systems Biomedicine
From genes to therapy – new concepts for personalized medicine and clinical decision support in Parkinson’s disease
|14.00 – 14.30:||Prof Geert Mortier, Antwerp University Hospital
Whole Exome Sequencing in a Clinical setting
|14.30 – 15.00:||Dr Erik Sistermans, VU University Medical Center
Bioinformatical and laboratory challenges in setting up NGS based genome wide cfDNA (NIPT & Liquid Biospsies)
|15.00 – 15.30:||Coffee, Exhibition & Networking|
|15.30 – 16.00:||Dr Jana Jeschke, Lab of Cancer Epigenetics, ULB
Cancer Epigenetics and Epigenomics are coming of age
|16.00 – 16.30:||Prof Tim Hubbard, Genomics England, UK
The 100,000 Genomes Project – transforming mainstream healthcare
CLINICAL NGS DATA ANALYSIS WORKSHOP
Led by BRIGHTcore & (IB)2
The course was intended for those working the wet lab who want to learn about bioinformatics workflows so that they can begin to analyse data themselves or keep an overview of the analysis that their own bioinformatic colleagues are providing for them.
AGENDA – WORKSHOP 14TH NOVEMBER BY BRIGHTCORE IN COLLABORATION WITH (IB)2
|08.30 – 09.00:||Registration|
|SESSION I||VARIANT FILTERING & CLASSIFICATION|
|09.00 – 09.30:||Introduction to NGS data interpretation: variant annotation, filtering and classification
Teachers: Sonia Van Dooren & Guillaume Smits
|09.30 – 11.00:||A practical approach for NGS variant interpretation (Highlander) (part I)
Teacher: Raphaël Helaers – Assistants: Nisha Limaye & Julie Soblet
|11.00 – 11.30:||Coffee Break|
|11.30 – 13.00:||A practical approach for NGS variant interpretation (Highlander) (part II)
Teacher: Raphaël Helaers – Assistants: Nisha Limaye & Julie Soblet
|13.00 – 14.00:||Lunch|
|SESSION II||CLINICAL & DISEASE DATABASES|
|14.00 – 14.45:||Clinical phenotyping & genotype-phenotype correlation (CliniPhenome)
Teacher: Didier Croes – Assistants: Sonia Van Dooren & Satyam Kapoor
|14.45 – 15.30:||Analysing digenic inheritance (DIDA)
Teacher: Tom Lenaerts – Assistants: Andrea Gazzo & Sofia Papadimitriou
|15.30 – 16.00:||Coffee Break|
|SESSION III||PATHOGENICITY PREDICTION|
|16.00 – 17:00:||Single amino acid variants: towards molecular phenotyping (Mutaframe and DEOGEN2)
Teachers: Wim Vranken & Ibrahim Tanyalcin – assistant: Francois Ancien
|17:00 – 17:30:||Predicting pathogenicity of digenic combinations (DI-Frame)
Teacher: Tom Lenaerts – Assistants: Sofia Papadimitriou & Andrea Gazzo
ULB – Campus Erasme
Room B1.004 (Building B on the campus map)
1070 Anderlecht (Brussels)
Click on map to expand.
For directions on how to get to ULB Erasme Campus, please view the ‘Venue & Directions’ tab.
If you have any queries about the workshop, feel free to CONTACT US
NEB: Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry, New England Biolabs (NEB) is now a recognized world leader in the discovery, development and commercialization of recombinant and native enzymes for genomic research.
NEB is renowned for consistently providing exceptional product quality and unsurpassed technical support. For over four decades, NEB has been shaping the landscape of bioscience research by discovering, developing and supporting innovative and superior research reagents and optimized enzymatic workflow solutions. NEB is continuously expanding its product offerings into new areas including Next-Generation-Sequencing, Epigenetics and Cellular Imaging.
BIOKÉ: Founded in 2004 in Leiden The Netherlands, BIOKÉ is an experienced and knowledgeable company that provides innovative products with the highest quality in the life science industry throughout Europe.
Since July 2009 we are the official EMEA base of operations for Cell Signaling Technology (CST). CST is the market leader in the development of high quality antibody products and technologies.
BIOKÉ delivers unique and high-performance applications and workflows for genomics, protein and cellular analysis and cell biology. Our team of professionals is carefully selected to form a company which has everything to make a collaboration a success. We provide you with customized solutions, including service support – not as a contractor, but as a knowledge partner.
Bluebee offers a cloud-based accelerated genomics analysis platform that facilitates fast and affordable data processing. Bluebee enables research and clinical labs to substantially reduce cost, complexity and throughput time of their data analysis and helps sequencing service providers as well as diagnostic test providers to effectively expand their offering and market reach. The highly secured platform offers scalable yet localized data processing and storage, while providing full control for configuration, sharing and collaboration. The combination of domain experts in the development and deployment of large scale mission-critical infrastructure, seasoned bioinformaticians and renowned academic researchers in high performance computing, led to the use of two disruptive technologies – cloud and HPC – combined to deliver a unique service.
PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. With our proprietary nucleic acid isolation technology, fully integrated automated library prep, robust sequencing chemistries, sample quality quantitation and visualization tools for analysis of complex sequencing data, we help you deliver top-quality samples for world-class genomics research from start to finish.
At Agilent, we strive to create full solutions to our customers, creating a seamless integration of instrumentation, consumables, software and services to deliver a consistent and easy-to-use experience. We are motivated to be more than vendors and build lasting partnerships with our customers.
Research and clinical professionals diagnose and monitor diseases through analysis of human genetic code using Agilent target enrichment solutions for next-generation sequencing and genomic microarrays. Agilent solutions range from genome-wide genetic analysis to the targeted detection of mutations at one or more loci and the analysis of changes in gene regulation. Our core genomics technologies include SureSelect and HaloPlex target enrichment systems, and microarrays using comparative genomics hybridization (CGH) and fluorescent in situ hybridization (FISH). Agilent delivers industry-leading solutions for pre-implantation human genetics and cancer genetics.
Multiplicom, a part of Agilent Technologies, has become a strong and reliable player in molecular diagnostics. Our products and solutions incorporate the latest medical findings on human genetics, oncology and prenatal testing and are developed and manufactured in compliance with the most stringent international quality standards. We provide your laboratory with a broad range of molecular Next-Generation Sequencing (NGS) solutions, which guide your laboratory towards the most reliable results. Our ready-to-use assays analyze the genes that matter in a simple, efficient and reliable manner. Our Reporter software ensures correct analysis and enables quality control. Our Expert customer support team helps you to set up your tests and secure your results in every step of the way.
Advanced Analytical Technologies Inc. (AATI) develops, manufactures and markets high-throughput, fully-automated nucleic acid and genetic analysis systems. The company’s products have both commercial and research applications and are designed to improve processes within the molecular diagnostics, pharmaceutical, life science, agricultural and biofuels industries. The company’s product portfolio includes instruments for the parallel analysis of biomolecules, DNA, RNA, genomic DNA, double-stranded DNA, gene editing (CRISPR/Cas9), pharmaceutical compounds and proteins using capillary electrophoresis (CE) with fluorescence detection or UV absorbance. The company’s flagship product, the Fragment Analyzer, is recognized as the best-in-class, multi-channel, automated fluorescence-based CE detection system for the simultaneous analysis of the quantity and quality of nucleic acids, including: dsDNA fragments, gDNA, NGS fragments and RNA (total and messenger) and microsatellites (SSR). Advanced Analytical Technologies, Inc. (AATI) simplifies complex genomics workflows to accelerate research and discovery in pharmaceuticals, life science, biofuels, biotechnology and healthcare. The company has facilities in Ames, Iowa, USA and Heidelberg, Germany. We support customers through a global network of distributors and support centers.
Takara Bio Europe is a wholly owned subsidiary of Takara Bio Inc., who develops, manufactures, and distributes a wide range of life science reagents under the Takara™, Clontech®, and Cellartis® brands.
Key products include SMART cDNA synthesis kits for a variety of samples and applications, including NGS, high-performance qPCR and PCR reagents (including the Takara Ex Taq®, Takara LA Taq®, Titanium®, and Advantage® enzymes), Cellartis stem cells and stem cell reagents, RT enzymes and SMART library construction kits, the innovative In-Fusion® cloning system, Guide-it gene editing tools, Tet-based inducible gene expression systems, and Living Colors® fluorescent proteins.
Recently, Takara Bio acquired Rubicon Genomics and WaferGen Bio-systems. As part of the Takara Bio family, they expand our NGS portfolio as well as add R&D, manufacturing, and support for automation systems for NGS and qPCR applications. Takara Bio’s portfolio supports applications including NGS, gene discovery, regulation, and function studies, as well as genetic analysis, protein expression and purification, gene editing, stem cell studies, and plant and food research. For more information, visit takarabio.com.
PRIMADIAG is an innovative French company developing simple and powerful robotic platforms for rapid automation of a wide variety of protocols in the area of biology in particularly molecular biology.
The ACSIA Line from PrimaDiag, is the solution for automation breaking with the current way of thinking to bring quality, cost efficiency and simplicity to all the laboratories in genomics and proteins.
PacBio is the leader in long-read sequencing, providing the most comprehensive views of genomes, transcriptomes, and epigenomes in a variety of organisms from viruses/bacteria through to plant, animal and human genomes. SMRT Sequencing delivers long continuous reads (>20kb), high consensus accuracy (up to 99.9999% QV50), uniform coverage (even across high GC content regions), along with simultaneous epigenetics characterization. PacBio DNA sequencing data reveals previously hidden structural variants and produces direct variant phasing information across haplotype blocks, in both whole genome and targeted applications. With SMRT Sequencing Systems, scientists gain new insight into the genetic basis of disease heritability and a more comprehensive view of genetic variation and the genetic basis of cancer risk, disease biology, and differential outcomes.
BGI was established in 1999 with participation in the original Human Genome Project. Since then, BGI has grown in to one of the world’s largest genomics organisations, experienced in genomic research, commercial NGS services and sequencer manufacturing. We are committed to providing solutions to address the research, pharmaceutical and clinical markets. With a focus on improving human health, we provide high quality sequencing services from our ISO15189 accredited laboratories, including WGS and exome sequencing, as well as a wide range of affordable genetic tests including non-invasive prenatal testing, carrier screening and hereditary cancer screening. To learn more, visit our website www.bgi.com/global/.
The Company: Since 2013, omicX, the French start-up founded by Arnaud Desfeux PhD, has been striving to democratize bioinformatics, by offering a practical work environment, dedicated to biological data analysis to assist life scientists identify the optimal tools for finding new entries from the omics data.
The platform: Research in bioinformatics is evolving in leaps and bounds. Finding the right solution for biomedical data analysis is a challenging and time-consuming task. OMICtools helps biologists and clinicians find the right tools to properly analyze each of the different steps in their experimental reasearch. Users can query a large repository of existing and emerging tools using a powerful search engine, with an algorithm delivering the best-adapted query interpretation. OMICtools is open to everyone who wants to share and discuss bioinformatics tools, and highlight their bioinformatics expertise.
Genome Diagnostics Nijmegen is an ISO 15189:2012 certified laboratory, which provides high quality and up to date diagnostics of genetic disorders for patients and their families. A full diagnostic interpretation of clinically relevant variants is offered. The laboratory has over 130 coworkers and performs >29.000 tests and >6000 diagnostic exomes each year. Genome Diagnostics Nijmegen is part of the Department of Human Genetics of the Radboud University Medical Center and is based in the Netherlands.
HOW TO GET TO MUSEUM OF MEDICINE (Musée de la Médecine), Campus Erasme
CONFERENCE VENUE: The Museum of Medicine (Musée de la Médecine) is located in the south of Brussels and is very conveniently connected by the Metro to Brussels City Centre. Below you can find a detailed map of the campus.
Museum of Medicine
Campus Erasme – Place Facultaire
1070 Anderlecht (Brussels)
TEL: +32 2 555 34 31
WORKSHOP VENUE (14th Nov only): the workshop will take place in room B1.004 at Campus Erasme. This is located in Building B, please refer to the campus map.
Please click on the map to expand.
CONFERENCE VENUE (15th & 16th Nov):
Musée de la Médecine is building number 17 on the map.
Please click on the map to expand.
Please click below on the blue text to view a satellite map view.
HOW TO GET TO ULB – CAMPUS ERASME
From the Brussels ‘Ring, take the exit “ULB Erasme” (N°16 or N° 15a), follow the signposts “ULB Hôpital Erasme”.
BY PUBLIC TRANSPORT
BY TRAIN – if you are travelling by train and arrive at one of the central stations in Brussels (Nord, Sud/Midi or Central), please get the Metro 5 (YELLOW LINE) from Brussels Central station to the Erasme Campus.
BY PLANE – If you arrive at Brussels Airport (Zaventem), you should get a train to Brussels Central (it takes 17 minutes). From Brussels Central please take Metro 5 (YELLOW LINE) and it takes 23 minutes to get to the Erasme station. Taking a taxi through Brussels will be very expensive and will take a lot longer so public transport is advised.
If you arrive at Charleroi Airport, you can get a shuttle bus into Brussels city centre (Gare du Midi). This costs around €14 one-way. From Brussels Midi/Sud Station the easiest way to reach the venue will be by taxi but you can also take a metro to Brussels Central and then get a metro to Erasme.
Metro: Line 5 (YELLOW) direction “Erasme”, stop at “Erasme”.
Tram: Line 23 direction “Heysel”, stop at “Montgomery”, take the underground line 1B and stop at “Hôpital Erasme” (terminus).
Bus: Line 98 : this bus ride between “Square des Héros”, “Uccle Stalle” and “Hôpital Erasme”.
This bus line is not available at night or Saturday, Sunday or bank holidays.
Bus De Lijn: 190 (from Brussels North Station to Anderlecht “Erasme”).
This bus line travels from “Porte d’anvers” to the underground’s lines “Ribaucourt”, “Gare de l’Ouest”, “Jacques Brel” and arrives to the Hôpital Erasme. via Chaussee de Mons.
141 (Brussels Chapel-Lennik-Leerbeek)
142 (Brussels Chapel-Gaasbeek-Leerbeek), through “Gare du Midi”.
There are 2 supervised payable car parks near the hospital. Parking is also possible on the street.
Car park “Erasme”: A covered car park open 24 hours a day located within the campus. The cost is €14.30 for 24 hours.
Car park “Lennik”: This is located just outside the campus and it’s open weekdays from 6:30am to 10:30pm. Closed on weekends and bank holidays. The cost is around €5 per day. Phone : 02/217 98 86
Click HERE for more Information about Campus Erasme